跳至主要内容
临床试验/NCT00774124
NCT00774124已完成不适用

Improving Outcomes in Underserved Women With GDM

Temple University4 个研究点 分布在 1 个国家目标入组 57 人开始时间: 2007年8月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
57
试验地点
4
主要终点
maternal blood glucose control

研究概览

简要总结

Our objective is to test an innovative approach to improve outcomes among underserved women with gestational diabetes. We ill utilize a multi-lingual, Interactive Voice Response (IVR) -enabled telephone system to facilitate diabetes control and thereby improve pregnancy outcomes. Our hypothesis is that Telemonitoring will improve maternal glycemia, thereby reducing infant birth weights and leading to improved pregnancy outcomes.

详细描述

Using a step care design, women will be randomized into standard of care or Telemonitoring. In the standard of care group, women will monitor their blood glucose levels four times a day, perform fetal movement counting three times a day and also record insulin doses. The women will record this information in a logbook, which will be reviewed by the medical team at prenatal visits. In the Telemonitoring group, women will receive the standard of care anmd will also transmit their blood glucose and fetal movement information to their health care providers.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
None

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • diagnosis of GDM
  • 33 or less weeks gestation

排除标准

  • multiple gestations
  • history of glucose intolerance outside of pregnancy

研究组 & 干预措施

1 Telemedicine

Experimental

Usual care plus telemonitoring

干预措施: telemonitoring (Other)

2 Standard of Care

Active Comparator

Standard of care - women will monitor and record blood glucose levels four times a day.

干预措施: Standard of care (Other)

结局指标

主要结局

maternal blood glucose control

时间窗: 3 to 9 months

次要结局

  • infant birthweight(at delivery)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验